What really lowers your risk of heart disease?
Nine factors explain roughly 90 percent of heart-attack risk, so quitting smoking, Mediterranean-style eating, movement and treated blood pressure and cholesterol probably matter most.
Nine factors explain about 90 percent of heart-attack risk worldwide, and most are within reach: not smoking, eating fruit and vegetables, regular movement, a healthy waistline, and controlled blood pressure, blood fats and blood sugar1. In trials, a Mediterranean diet with olive oil or nuts cut major events by about 30 percent2, and a lower blood-pressure target cut them by about a quarter3. Lifestyle works alongside medication, not instead of it.
What you can do
- If you smoke, quitting is the biggest single step: stopping before age 40 removed about 90 percent of smoking's added risk of death7.
- Eat Mediterranean-style, with extra-virgin olive oil or mixed nuts as staples; in the PREDIMED trial this cut major events by about 30 percent2.
- Move more, know your numbers: inactive to 150 weekly minutes of moderate activity was linked to 17 percent fewer cardiovascular cases; treating high blood pressure or cholesterol lowers risk6,3,10.
Be careful if
- Sudden chest pain, breathlessness, a drooping face or weakness on one side need emergency care now, not lifestyle changes: see when home remedies are not enough.
- With heart disease, do not stop aspirin, a statin or beta-blocker alone: after heart attack, stopping all three carried 3.8 times the one-year death risk of staying on one11.
- Do not start daily aspirin for prevention by yourself: in healthy adults 70 or older it did not lower cardiovascular events and raised major bleeding by 38 percent12.
Go deeper
How it works What it does in your body, in plain words 2 min
The nine factors
INTERHEART compared 15,152 people who had a first heart attack with 14,820 controls in 52 countries. Eight modifiable factors (smoking, the apoB/apoA1 blood-fat ratio, high blood pressure, diabetes, abdominal obesity, psychosocial stress, low fruit-and-vegetable intake and inactivity), plus alcohol intake, together accounted for 90 percent of the population-attributable risk in men and 94 percent in women, and the associations held in every region1.
Food, with the trials behind it
- Mediterranean diet. In PREDIMED, 7,447 adults at high risk who were given extra-virgin olive oil or mixed nuts had about 30 percent fewer major events (heart attack, stroke or cardiovascular death) over 4.8 years than adults advised to cut fat2. After a first heart attack, the Lyon Diet Heart trial's Mediterranean-style diet also cut cardiac death and repeat infarction (14 events versus 44)4. See Mediterranean diet.
- DASH-style eating. Plenty of fruit, vegetables and low-fat dairy lowered systolic pressure 5.5 mm Hg more than a low-fruit, low-vegetable control diet in 459 adults, and 11.4 mm Hg more in those with hypertension5. See blood pressure.
Movement, tobacco and sleep
Going from inactive to 150 minutes a week of moderate activity was linked to 17 percent lower cardiovascular disease incidence and 23 percent lower cardiovascular mortality, with the biggest gain from the first small amounts6. Smokers lose at least a decade of life, and quitting before 40 cut the added risk of death by about 90 percent7. The American Heart Association's Life's Essential 8 score puts sleep alongside diet, activity, nicotine, weight, blood fats, blood sugar and blood pressure8.
Genes are not destiny
Among 55,685 people, a favorable lifestyle went with a 46 percent lower risk of coronary events even in those at high genetic risk9.
When medicine is the right tool
Lifestyle and medicine are partners. Aiming for a systolic pressure under 120 mm Hg instead of 140 cut major events by 25 percent in 9,361 high-risk adults without diabetes, though low blood pressure and kidney problems were more common3. Statins lower the risk of heart attack and stroke in proportion to the fall in LDL10; see what lowers cholesterol. Even on the Mediterranean diet, cholesterol and blood pressure still predicted a second event in the Lyon trial4.
Go deeper: atherosclerosis, triglycerides and lipoprotein(a).
The evidence The studies, what they found, and how much to trust them 4 min · 12 sources
INTERHEART
Smoking (odds ratio 2.87 for current versus never; population-attributable risk 35.7 percent), a raised apoB/apoA1 ratio (3.25, top versus bottom fifth; 49.2 percent), hypertension (1.91; 17.9 percent), diabetes (2.37; 9.9 percent), abdominal obesity (20.1 percent), psychosocial factors (2.67; 32.5 percent), lacking daily fruit and vegetables (0.70 for having them; 13.7 percent) and regular exercise (0.86; 12.2 percent) were all linked to infarction in men and women, young and old. Regular alcohol was modestly inversely associated (0.91), which observational data cannot separate from other habits. The case-control design relies on recall and shows association, not proof of cause1.
The diet trials
PREDIMED randomized 7,447 Spanish adults aged 55 to 80 at high cardiovascular risk to a Mediterranean diet with extra-virgin olive oil, a Mediterranean diet with mixed nuts, or advice to cut dietary fat. Over a median 4.8 years, 288 had a major event: 96 (3.8 percent), 83 (3.4 percent) and 109 (4.4 percent). Adjusted hazard ratios were 0.69 (95% CI 0.53 to 0.91) for olive oil and 0.72 (0.54 to 0.95) for nuts2. This is a corrected analysis: the investigators withdrew their 2013 report after finding protocol deviations, including household members enrolled without randomization and some participants at one of 11 sites not randomized. Results were similar after omitting 1,588 participants whose assignment was known or suspected to depart from protocol2.
The Lyon Diet Heart Study randomized survivors of a first heart attack to a Mediterranean-type or a prudent Western-type diet. Over a mean 46 months, cardiac death plus nonfatal infarction occurred 14 times versus 44, with adjusted risk ratios of 0.28 to 0.53 across outcome definitions. Cholesterol, blood pressure, white-cell count and aspirin use still predicted recurrence, so the authors advised pairing diet with other, possibly drug, risk-factor treatment4. DASH was a feeding trial: 459 adults ate a control diet, a fruit-and-vegetable diet or a combination diet for eight weeks, with sodium and weight held constant. The combination diet lowered pressure 5.5/3.0 mm Hg more than control, and 11.4/5.5 mm Hg more in the 133 people with hypertension5.
Pressure, activity and tobacco
SPRINT randomized 9,361 adults with systolic pressure of 130 mm Hg or higher, extra cardiovascular risk and no diabetes to a target under 120 or under 140. It stopped early at a median 3.26 years: the primary outcome occurred at 1.65 versus 2.19 percent a year (hazard ratio 0.75, 0.64 to 0.89) and all-cause death was lower (0.73, 0.60 to 0.90), but serious hypotension, fainting, electrolyte problems and kidney injury were more frequent3. A meta-analysis of 36 studies (3,439,874 participants) put the move from inactive to 150 minutes a week at relative risks of 0.83 for cardiovascular disease incidence and 0.77 for mortality6. In a US survey of 202,248 adults, current smokers died at about three times the rate of never-smokers, and quitting at 25 to 34, 35 to 44 or 45 to 54 gained about 10, 9 and 6 years of life7.
Genes, medicines and what not to take
In four studies of 55,685 people, high genetic risk raised coronary events (hazard ratio 1.91 for top versus bottom fifth). Among those at high genetic risk, a favorable lifestyle (at least three of: no smoking, no obesity, regular activity, healthy diet) went with a 46 percent lower risk (0.54, 0.47 to 0.63); in one cohort the 10-year incidence fell from 10.7 to 5.1 percent9. Pooled statin trials found a 22 percent fall in major vascular events per 1 mmol/L fall in LDL (rate ratio 0.78)10.
In a registry of 1,521 people discharged on aspirin, a beta-blocker and a statin, the 184 who stopped all three within a month had lower one-year survival than those who kept taking at least one (88.5 versus 97.7 percent; adjusted hazard ratio 3.81, 1.88 to 7.72), though people who stop medicines may differ in other ways11.
Null results and limits
More is not always better. In ASPREE, 19,114 healthy adults aged 70 or older took aspirin 100 mg or placebo for a median 4.7 years. Cardiovascular events were 10.7 versus 11.3 per 1,000 person-years (0.95, 0.83 to 1.08), while major bleeding was 8.6 versus 6.2 (1.38, 1.18 to 1.62)12. Life's Essential 8 is a scoring framework, with 0 to 100 points for each of eight metrics, not a trial8. The exercise and smoking figures come from population studies, so they show association rather than proof, and PREDIMED's comparison group was low-fat advice rather than a usual diet.
Bottom line
Confidence is fairly high (4 of 5). Randomized trials support Mediterranean eating and blood-pressure treatment2,3, large cohorts support movement and not smoking6,7, and medicines such as statins add protection when risk is high10. Diet trials with heart-attack endpoints are few, so treat food as strong but not fully proven prevention.
Sources
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Yusuf S, Hawken S, Ounpuu S, et al.. Lancet, 2004. PubMed 15364185
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. Estruch R, Ros E, Salas-Salvadó J, et al.. N Engl J Med, 2018. PubMed 29897866
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control. Wright JT Jr, Williamson JD, Whelton PK, et al. (SPRINT Research Group). N Engl J Med, 2015. PubMed 26551272
- Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. de Lorgeril M, Salen P, Martin JL, et al.. Circulation, 1999. PubMed 9989963
- A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. Appel LJ, Moore TJ, Obarzanek E, et al.. N Engl J Med, 1997. PubMed 9099655
- Quantifying the Association Between Physical Activity and Cardiovascular Disease and Diabetes: A Systematic Review and Meta-Analysis. Wahid A, Manek N, Nichols M, et al.. J Am Heart Assoc, 2016. PubMed 27628572
- 21st-century hazards of smoking and benefits of cessation in the United States. Jha P, Ramasundarahettige C, Landsman V, et al.. N Engl J Med, 2013. PubMed 23343063
- Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. Lloyd-Jones DM, Allen NB, Anderson CAM, et al.. Circulation, 2022. PubMed 35766027
- Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. Khera AV, Emdin CA, Drake I, et al.. N Engl J Med, 2016. PubMed 27959714
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Baigent C, Blackwell L, Emberson J, et al. (Cholesterol Treatment Trialists' (CTT) Collaboration). Lancet, 2010. PubMed 21067804
- Impact of medication therapy discontinuation on mortality after myocardial infarction. Ho PM, Spertus JA, Masoudi FA, et al.. Arch Intern Med, 2006. PubMed 17000940
- Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. McNeil JJ, Wolfe R, Woods RL, et al.. N Engl J Med, 2018. PubMed 30221597